Biocon

Biocon

World Rank (Aug-2026)
2848
Market Cap (Aug-2026)
7.055 Billion USD
Market Cap (Mar-08-2026)
6.873 Billion USD
World Rank (Jan-05-2024)
3,442
Market Cap (Jan-05-2024)
4.090 Billion USD
World Rank (Jul-30-2023)
3,712
Market Cap (Jul-30-2023)
3.746 Billion USD
World Rank (Jan-07-2022)
2,935
Market Cap (Jan-07-2022)
5.764 Billion USD
World Rank (Jan-01-2021)
2,089
Market Cap (Jan-01-2021)
7.644 Billion USD
Company Rank in Country in 2023
Rank in India in July-2023 is 184
Headquarters Country
India
Top Healthcare Companies in India
Top Technology Companies in India
Top Pharmaceutical Companies in India
Billionaires
Kiran Mazumdar-Shaw
Employee Count
12,000
Employee Count as of Date
As on 2020
Headquarters City/State
Bangalore
World Region
Asia
World Subregion
Southern Asia
Annual Revenue in USD
1,812 Million USD
Annual Operating Income in USD
186 Million USD
Annual Net Income in USD
42 Million USD
Annual Results for Period Ending
For year ending March-2026
Total Assets in USD
6,873 Million USD
Total Liabilities in USD
2,919 Million USD
Total Equity in USD
3,954 Million USD
Balance Sheet for Period Ending
As of March-2026
Business Sector
Healthcare
Pharmaceutical
Biopharmaceutical
Biotechnology
Technology
Company Website
BIOCON LIMITED
Wikipedia
Wikipedia
Yahoo
Yahoo @ BSE
Company Profile

Biocon is India's largest Bio-pharmaceutical company with headquarters is in Bangalore, India. As on 2020, it has 12,000 employees and 1220 patents and 900 Registered Trademarks and they supply their products to 120 countries.

Key therapeutic areas are diabetes, oncology, immunology, agriculture of innovation.

Annual Results Summary

BIOCON - Consolidated - Annual Results Summary - in Crores INR:

Year EndingTotal IncomeNet ProfitEPS (INR)
Mar-202311,1744623.88
Mar-20228,1846485.44
Mar-20217,1069256.24
Mar-20206,5288996.32
Mar-20195,6581,0017.65
Mar-20184,3294316.31
Mar-20174,04867131.18
Founded Year
1978
ISIN Code
INE376G01013
Stock Category
S&P BSE HEALTH CARE
Stock Exchange
BSE
NSE

Share